Announcements Trials
Browse Landscape

Status

Recruiting 3Unknown 2Completed 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Kidney Failure, Chronic 1

Interventions

Specimen Handling 5Observation 4Blood Specimen Collection 4Surveys and Questionnaires 3Drug Therapy 3Chemoradiotherapy 3Surgical Procedures, Operative 2Electrocardiography 2Echocardiography 2Capecitabine 2Biopsy 2trifluridine tipiracil drug combination 1tegafur-gimeracil-oteracil 1somapacitan 1olverembatinib 1lorlatinib 1lenvatinib 1gallium 68 PSMA-11 1brexucabtagene autoleucel 1axicabtagene ciloleucel 1Zoledronic Acid 1Tumor Burden 1Telemedicine 1Tegafur 1Stents 1S 1 (combination) 1Robotic Surgical Procedures 1Rituximab 1Radiotherapy 1Radiography, Panoramic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Observational × Pancreatectomy × Clear all
NCT07405099 2026-02-27

Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease

National Taiwan University Hospital

Enrolling by invitation
100 enrolled
GastrointestinalGenitourinary

Kidney Failure, Chronic, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡